CAR T Cells: Keeping Pace With Adverse Effects of an Emerging Therapy – Oncology Nurse Advisor

Posted: May 7, 2017 at 9:41 am


Oncology Nurse Advisor
CAR T Cells: Keeping Pace With Adverse Effects of an Emerging Therapy
Oncology Nurse Advisor
Chimeric antigen receptor T cells (CAR T cells) are human T cells that are collected from the patient and genetically modified to express a CAR immunoreceptor. The modified CAR T cells target specific surface proteins on cancer cells. CAR T cell ...

Read more:
CAR T Cells: Keeping Pace With Adverse Effects of an Emerging Therapy - Oncology Nurse Advisor

Related Posts